OnKure Therapeutics, Inc. (OKUR)

NASDAQ: OKUR · Real-Time Price · USD

2.410

+0.110 (4.78%)

At close: Oct 9, 2026, 4:00 PM EDT

2.430

+0.020 (0.83%)

After-hours: Oct 9, 2026, 6:09 PM EDT

OnKure Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	166.5	59.05	110.76	29.88	11.54
Cash & Short-Term Investments	176.39	59.05	110.76	29.88	11.54
Cash Growth	111.56%	-46.69%	270.74%	158.82%	-
Prepaid Expenses	1.29	1.79	2.24	3.89	2.08
Total Current Assets	177.68	60.84	113	33.77	13.62
Property, Plant & Equipment	1.28	1.01	1.8	1.91	2.05
Other Long-Term Assets	0.4	0.27	0.11	0.06	0.33
Total Assets	179.35	62.12	114.91	35.73	16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	2	1.43	2.97	3.42	2.52
Accrued Expenses	4.31	3.94	7.03	3.66	2.87
Current Portion of Leases	0.34	0.55	0.54	0.21	0.15
Total Current Liabilities	6.64	5.92	10.53	7.29	5.54
Long-Term Leases	0.59	-	0.55	0.47	0.49
Other Long-Term Liabilities	0.01	0.01	-	-	-
Total Liabilities	7.25	5.93	11.08	7.75	6.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0	0	0	-	0
Additional Paid-In Capital	416.86	270.42	258.55	0.21	2.66
Retained Earnings	-244.74	-214.24	-154.72	-102.05	-57.07
Total Common Equity	172.11	56.18	103.83	-101.84	-54.42
Shareholders' Equity	172.11	56.18	103.83	27.98	9.97
Total Liabilities & Equity	179.35	62.12	114.91	35.73	16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	0.93	0.55	1.09	0.67	0.64
Net Cash (Debt)	175.46	58.5	109.68	29.2	10.91
Net Cash Growth	112.55%	-46.66%	275.58%	167.76%	-
Net Cash Per Share	7.72	4.33	31.82	102.89	-
Filing Date Shares Outstanding	40.5	13.67	13.44	13.34	-
Total Common Shares Outstanding	40.5	13.67	13.35	13.34	-
Working Capital	171.03	54.92	102.47	26.48	8.08
Book Value Per Share	4.25	4.11	7.78	-7.63	-
Tangible Book Value	172.11	56.18	103.83	-101.84	-54.42
Tangible Book Value Per Share	4.25	4.11	7.78	-7.63	-
Machinery	0.99	0.99	1.05	1.01	0.85
Leasehold Improvements	1.09	1.09	1.09	1.09	1

SEC Filings: 10-K · 10-Q